var data={"title":"Vitamin A: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Vitamin A: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/7155?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=vitamin-a-patient-drug-information\" class=\"drug drug_patient\">see &quot;Vitamin A: Patient drug information&quot;</a> and <a href=\"topic.htm?path=vitamin-a-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Vitamin A: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234440\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>A-25 [OTC];</li>\n      <li>AFirm 1X [OTC] [DSC];</li>\n      <li>AFirm 2X [OTC] [DSC];</li>\n      <li>AFirm 3X [OTC] [DSC];</li>\n      <li>Aquasol A;</li>\n      <li>Gordons-Vite A [OTC];</li>\n      <li>Vitamin A Fish [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234456\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Vitamin, Fat Soluble</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234443\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Deficiency (manufacturer recommendation):</b> IM: <b>Note:</b> IM route is indicated when oral administration is not feasible or when absorption is insufficient (malabsorption syndrome): 100,000 units/day for 3 days, followed by 50,000 units/day for 2 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Note:</b> Follow-up therapy with an oral therapeutic multivitamin (containing additional vitamin A) is recommended: Oral: 10,000 to 20,000 units/day for 2 months</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Deficiency (high-dose supplementation in patients at high risk for deficiency) (off-label dose)</b> (eg, persons living in developing areas of the world where deficiency is a public health problem, especially persons with severe infectious disease or malnutrition): Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Adults: 200,000 units/dose every 6 months (WHO 2008)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pregnant females: Maximum 10,000 units daily or 25,000 units once weekly. Administer for a minimum of 12 weeks during pregnancy or until delivery (WHO 2008; WHO 2011c)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Postpartum females: 200,000 units at delivery or within 8 weeks of delivery (WHO 2008)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Xerophthalmia, treatment (off-label use):</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Adults (except females of reproductive age): 200,000 units once daily for 2 days; repeat with single dose after 2 weeks (WHO 2008)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Females of reproductive age (WHO 1997; WHO 2008):</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">With night blindness or Bitot's spots (less severe xerophthalmia): 5,000 to 10,000 units daily (maximum 10,000 units/day) or &le;25,000 units once weekly for &ge;4 weeks</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Severe xerophthalmia: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234451\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=vitamin-a-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Vitamin A: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Deficiency (manufacturer recommendation):</b> IM: <b>Note:</b> IM route is indicated when oral administration is not feasible or when absorption is insufficient (malabsorption syndrome):</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants: 7,500 to 15,000 units/day for 10 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 1 to 8 years: 17,500 to 35,000 units/day for 10 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &gt;8 years: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Note:</b> Follow-up therapy with an oral therapeutic multivitamin (containing additional vitamin A) is recommended: Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Low Birth Weight Infants: Additional vitamin A is recommended; however, no dosage amount has been established.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &le;8 years: 5,000 to 10,000 units/day for 2 months</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &gt;8 years: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Deficiency (high-dose supplementation in patients at high risk for deficiency) (off-label dose)</b> (eg, persons living in developing areas of the world where deficiency is a public health problem, especially persons with severe infectious disease or malnutrition): Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants &lt;6 months: Not recommended (WHO 2011a)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants 6 to 12 months: 100,000 units/dose; repeat every 4 to 6 months, but do not readminister within 30 days of previous dose (WHO 1997; WHO 2010)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &gt;1 year: 200,000 units/dose; repeat every 4 to 6 months, but do not readminister within 30 days of previous dose (WHO 1997; WHO 2010)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Measles, treatment (off-label use)</b> (WHO 2004; WHO 2010): Oral: <b>Note:</b> Repeat with single dose in 2 to 4 weeks if severe malnutrition exists or ophthalmic evidence of a vitamin deficiency is present:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants &lt;6 months: 50,000 units once daily for 2 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants 6 to 11 months: 100,000 units once daily for 2 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &gt;11 months to 5 years: 200,000 units once daily for 2 days</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Xerophthalmia, treatment (off-label use):</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants &lt;6 months: 50,000 units once daily for 2 days; repeat with single dose after 2 weeks (WHO 2010)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants 6 to 12 months: 100,000 units once daily for 2 days; repeat with single dose after 2 weeks (WHO 2010)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children and Adolescents: 200,000 units once daily for 2 days; repeat with single dose after 2 weeks (WHO 2008)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Females of reproductive age: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234444\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50847059\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50847060\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234422\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">A-25: 25,000 units</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Vitamin A Fish: 7500 units</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 10,000 units</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">A-25: 25,000 units [dye free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 8000 units</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">AFirm 1X: 0.15% (30 g [DSC]) [fragrance free; contains benzyl alcohol, cetyl alcohol, disodium edta, methylparaben, peg-10 soya sterol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">AFirm 2X: 0.3% (30 g [DSC]) [fragrance free; contains benzyl alcohol, cetyl alcohol, disodium edta, methylparaben, peg-10 soya sterol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">AFirm 3X: 0.6% (30 g [DSC]) [fragrance free; contains benzyl alcohol, cetyl alcohol, disodium edta, methylparaben, peg-10 soya sterol, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Gordons-Vite A: 100,000 units/g (75 g, 120 g, 480 g, 2400 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Gordons-Vite A: 100,000 units (120 mL, 4000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Intramuscular: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Aquasol A: 50,000 units/mL (2 mL) [contains chlorobutanol (chlorobutol)]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 10,000 units, 15,000 units, Vitamin A 10000 units and beta carotene 1000 units</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234408\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234425\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">May be administered orally or IM. <b>Note: IV administration is contraindicated.</b></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234424\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Treatment and prevention of vitamin A deficiency; parenteral (IM) route is indicated when oral administration is not feasible or when absorption is insufficient (malabsorption syndrome); dietary supplement (OTC) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25744936\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Measles (prevention of complications) (children); Xerophthalmia caused by vitamin A deficiency</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234464\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Aquasol may be confused with Anusol</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234415\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">Frequency not defined: Hypersensitivity: Anaphylactic shock (following IV administration), hypersensitivity reaction (rare)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234428\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to vitamin A or any component of the formulation; hypervitaminosis A; pregnancy (dose exceeding RDA); intravenous administration of Aquasol A</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234412\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Parenteral vitamin A: In low birth weight infants, polysorbates have been associated with thrombocytopenia, renal dysfunction, hepatomegaly, cholestasis, ascites, hypotension, and metabolic acidosis (E-Ferol syndrome).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). Hypersensitivity reactions, usually a delayed reaction, have been reported following exposure to pharmaceutical products containing polysorbate 80 in certain individuals (Isaksson 2002; Lucente 2000; Shelley 1995). Thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported in premature neonates after receiving parenteral products containing polysorbate 80 (Alade 1986; CDC 1984). See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Evaluate other sources of vitamin A while receiving this product; patients receiving &gt;25,000 units/day should be closely monitored for toxicity.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300220\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234417\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=10047&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Bexarotene (Topical): Vitamin A may enhance the adverse/toxic effect of Bexarotene (Topical).  Management: Limit doses of vitamin A to 5,000 units per day if combined with topical bexarotene.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Orlistat: May decrease the serum concentration of Vitamins (Fat Soluble). Management: Administer oral fat soluble vitamins at least 2 hours before or after the administration of orlistat.  Similar precautions do not apply to parenterally administered fat soluble vitamins.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Retinoic Acid Derivatives: Vitamin A may enhance the adverse/toxic effect of Retinoic Acid Derivatives. <b> Exceptions: </b>Adapalene; Alitretinoin (Topical); Bexarotene (Topical); Tretinoin (Topical).<i> Risk X: Avoid combination</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F14315239\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;display:inline\">Excessive ethanol intake depletes the liver of vitamin A and may enhance vitamin A toxicity (IOM 2000)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234419\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">X (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234431\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have been observed in animal reproduction studies. In humans, the critical period of exposure is the first trimester of pregnancy. Excess vitamin A during pregnancy may cause craniofacial malformations, as well as CNS, heart, and thymus abnormalities. Maternal vitamin A deficiency also causes adverse effects in the fetus, and vitamin A requirements are increased in pregnant women (IOM 2000). The manufacturer notes that the safety of doses &gt;6,000 units/day in pregnant women has not been established and doses greater than the RDA are contraindicated in pregnant women or those who may become pregnant. High doses are used in some areas of the world for supplementation where deficiency is a public health problem (eg, to prevent night blindness); however, single doses &gt;25,000 units should be avoided within 60 days of conception. High-dose supplementation is otherwise not recommended as part of routine antenatal care (WHO 2011c).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F14315219\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Vitamin A requirements are increased in breastfeeding women (IOM 2000). High-dose supplementation (eg, doses higher than the RDA) is not recommended in otherwise healthy women who receive adequate nutrition (WHO 2011b)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F14315240\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Dairy products, fish, and liver are common dietary sources of vitamin A; broccoli, cantaloupe, carrots, peas, spinach, and squash are sources of beta-carotene (which is converted to vitamin A) (IOM 2000)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary reference Intake </b>(presented as retinol activity equivalent [RAE]) (IOM 2001):</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 6 months: Adequate intake: 400 mcg/day (1,330 units/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">7 to 12 months: Adequate intake: 500 mcg/day (1,670 units/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 3 years: RDA: 300 mcg/day (1,000 units/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">4 to 8 years: RDA: 400 mcg/day (1,330 units/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">9 to 13 years: RDA: 600 mcg/day (2,000 units/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&gt;13 years: RDA: Females: 700 mcg/day (2,330 units/day); Males: 900 mcg/day (3,000 units/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pregnancy: RDA: 14 to 18 years: 750 mcg/day (2,500 units/day); &ge;19 years: 770 mcg/day (2,560 units/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Lactation: RDA: 14 to 18 years: 1,200 mcg/day (4,000 units/day); &ge;19 years: 1,300 mcg/day (4,330 units/day)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50847061\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Serum retinol</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234423\" class=\"block rer drugH1Div\"><span class=\"drugH1\">Reference Range</span>\n    <p style=\"text-indent:0em;display:inline\">RAE = Retinol activity equivalent; 1 RAE = retinol 1 mcg or dietary beta-carotene 12 mcg; Retinol 1 mcg = vitamin A 3.33 units (IOM 2001)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234411\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Vitamin A is a fat soluble vitamin needed for visual adaptation to darkness, maintenance of epithelial cells, immune function and embryonic development.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F234427\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Vitamin A in dosages <b>not</b> exceeding physiologic replacement is well absorbed in the small intestine after oral administration; water miscible preparations are absorbed more rapidly than oil preparations; large oral doses, conditions of fat malabsorption, low protein intake, or hepatic or pancreatic disease reduces oral absorption </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Large amounts concentrate for storage in the liver</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Converted in the small intestine to retinol and further metabolized in the liver; conjugated with glucuronide; undergoes enterohepatic recirculation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Feces; urine</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16324099\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Vitamin A Fish Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7500 unit (100): $2.55</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Vitamin A Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">8000 unit (100): $2.39</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10000 unit (100): $2.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Gordons-Vite A External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100000 units/g (120 g): $15.75</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Gordons-Vite A External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100000 unit (120 mL): $7.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Aquasol A Intramuscular)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">50000 units/mL (2 mL): $120.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Vitamin A-Beta Carotene Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10000-1000 unit (90): $8.49</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5539954\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>A Grin (MX);</li>\n      <li>A313 (FR);</li>\n      <li>Acon (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Arovit (AE, BE, BH, BR, CO, CY, EC, EG, IL, IQ, IR, IT, JO, KW, LB, LY, OM, PE, QA, SA, SE, SY, YE);</li>\n      <li>Avibon (FR);</li>\n      <li>Avitan (GR);</li>\n      <li>Avitina (IT);</li>\n      <li>Avitol (AT);</li>\n      <li>Davitamon A (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Ro-A-Vit (GH, KE, TZ, UG, ZM);</li>\n      <li>Vitamin A (AU)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Alade SL, Brown RE, Paquet A Jr. Polysorbate 80 and E-Ferol toxicity.<i> Pediatrics</i>. 1986;77(4):593-597.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/3960626/pubmed\" target=\"_blank\" id=\"3960626\">3960626</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Aquasol A Parenteral (water-miscible vitamin A palmitate) [prescribing information]. Lake Forest, IL: Hospira; September 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Braitberg G, Curry SC, and Kunkel DB, &ldquo;Liver Pathology in Fatal Vitamin A Toxicity,&rdquo; <i>Clin Toxicol</i>, 1995, 33(5):551-2.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product.<i> MMWR Morb Mortal Wkly Rep</i>. 1984;33(14):198-199.<a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/6423951/pubmed\" target=\"_blank\" id=\"6423951\">6423951</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cetaruk EW, Aaron CK. Hazards of nonprescription medications. <i>Emerg Med Clin North Am.</i> 1994;12(2):483-510.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/8187693/pubmed\" target=\"_blank\" id=\"8187693\">8187693</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cohen V, Jellinek SP, Teperikidis L, et al, &ldquo;Room-Temperature Storage of Medications Labeled for Refrigeration,&rdquo; <i>Am J Health-Syst Pharm</i>, 2007, 64(16):1711-15.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/17687059/pubmed\" target=\"_blank\" id=\"17687059\">17687059</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Committee on Infectious Diseases, &ldquo;Vitamin A in the Treatment of Measles,&rdquo; <i>Pediatrics</i>, 1993, 91(5):1014-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/8474793/pubmed\" target=\"_blank\" id=\"8474793\">8474793</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    de Francisco A, Chakraborty J, Chowdhury HR, et al, &ldquo;Acute Toxicity of Vitamin A Given With Vaccines in Infancy,&rdquo; <i>Lancet</i>, 1993, 342(8870):526-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/8102669/pubmed\" target=\"_blank\" id=\"8102669\">8102669</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    DeMaeyer EM, &ldquo;The WHO Programme of Prevention and Control of Vitamin A Deficiency, Xerophthalmia, and Nutritional Blindness,&rdquo; <i>Nutr Health</i>, 1986, 4(2):105-12.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/3090484/pubmed\" target=\"_blank\" id=\"3090484\">3090484</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hussey GD and Klein M, &ldquo;A Randomized, Controlled Trial of Vitamin A in Children With Severe Measles,&rdquo; <i>N Engl J Med</i>, 1990, 323(3):160-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/2194128/pubmed\" target=\"_blank\" id=\"2194128\">2194128</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine), <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>, Washington, DC: National Academy Press, 2000.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. Washington, DC: National Academy Press, 2001.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Isaksson M, Jansson L. Contact allergy to Tween 80 in an inhalation suspension. <i>Contact Dermatitis</i>. 2002;47(5):312-313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/12534540/pubmed\" target=\"_blank\" id=\"12534540\">12534540</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kowalski TE, Falestiny M, Furth E, et al, &ldquo;Vitamin A Hepatotoxicity: A Cautionary Note Regarding 25,000 IU Supplements,&rdquo; <i>Am J Med</i>, 1994, 97(6):523-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/7985711/pubmed\" target=\"_blank\" id=\"7985711\">7985711</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    LaMantia RS and Andrews CE, &ldquo;Acute Vitamin A Intoxication,&rdquo; <i>South Med J</i>, 1981, 74(8):1012-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/7268481/pubmed\" target=\"_blank\" id=\"7268481\">7268481</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lucente P, Iorizzo M, Pazzaglia M. Contact sensitivity to Tween 80 in a child. <i>Contact Dermatitis</i>. 2000;43(3):172.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/10985636/pubmed\" target=\"_blank\" id=\"10985636\">10985636</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Nesher G and Zuckner J, &ldquo;Rheumatologic Complications of Vitamin A and Retinoids,&rdquo; <i>Semin Arthritis Rheum</i>, 1995, 24(4):291-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/7740309/pubmed\" target=\"_blank\" id=\"7740309\">7740309</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"1978177\"></a>Sanders TA. Vitamin A and pregnancy. <i>Lancet. </i>1990;336(8727):1375.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/1978177/pubmed\" target=\"_blank\" id=\"1978177\">1978177</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity.<i> Lancet</i>. 1995;345(8960):1312-1313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/7746084/pubmed\" target=\"_blank\" id=\"7746084\">7746084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"6147616\"></a>White JM. Vitamin-A-induced anaemia. <i>Lancet. </i>1984;2(8402):573.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/6147616/pubmed\" target=\"_blank\" id=\"6147616\">6147616</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    WHO Guideline, &quot;Vitamin A Supplementation in Infants 1&ndash;5 Months of Age,&quot; Geneva: World Health Organization, 2011a. Available at http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_infants_1-5/en/</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    WHO Guideline, &quot;Vitamin A Supplementation in Postpartum Women,&quot; Geneva: World Health Organization, 2011b. Available at http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_postpartum/en/</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    WHO Guideline, &quot;Vitamin A Supplementation in Pregnant Women,&quot; Geneva: World Health Organization, 2011c. Available at http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_pregnant/en/</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      WHO Model Formulary, 2008. Available at http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      WHO Model Formulary for Children, 2010. Available at http://apps.who.int/medicinedocs/documents/s17151e/s17151e.pdf</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    WHO/UNICEF/IVACG Task Force, Vitamin A Supplements. A Guide to Their Use in the Treatment and Prevention of Vitamin A Deficiency and Xerophthalmia, 2nd ed. Geneva: World Health Organization, 1997. Available at http://www.who.int/nutrition/publications/micronutrients/vitamin_a_deficiency/9241545062/en/</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 10047 Version 111.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F234440\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F234456\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F234443\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F234451\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F234444\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F50847059\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F50847060\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F234422\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F234408\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F234425\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F234424\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25744936\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F234464\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F234415\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F234428\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F234412\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300220\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F234417\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F14315239\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F234419\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F234431\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F14315219\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F14315240\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F50847061\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Reference Range\" href=\"#F234423\" class=\"outlineLink\">Reference Range</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F234411\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F234427\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16324099\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F5539954\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/10047|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=vitamin-a-patient-drug-information\" class=\"drug drug_patient\">Vitamin A: Patient drug information</a></li><li><a href=\"topic.htm?path=vitamin-a-pediatric-drug-information\" class=\"drug drug_pediatric\">Vitamin A: Pediatric drug information</a></li></ul></div></div>","javascript":null}